(Q40310685)

English

Insulin-like growth factor-binding protein-5 activates plasminogen by interaction with tissue plasminogen activator, independently of its ability to bind to plasminogen activator inhibitor-1, insulin-like growth factor-I, or heparin

scientific article published on 27 February 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 September 2017

Insulin-like growth factor-binding protein-5 activates plasminogen by interaction with tissue plasminogen activator, independently of its ability to bind to plasminogen activator inhibitor-1, insulin-like growth factor-I, or heparin (English)

1 reference

Europe PubMed Central

19 September 2017

1 reference

based on heuristic

inferred from title

author name string

Alice M Sorrell

1

1 reference

Europe PubMed Central

19 September 2017

John H Shand

2

1 reference

Europe PubMed Central

19 September 2017

Elizabeth Tonner

3

1 reference

Europe PubMed Central

19 September 2017

Matteo Gamberoni

4

1 reference

Europe PubMed Central

19 September 2017

Pier A Accorsi

5

1 reference

Europe PubMed Central

19 September 2017

James Beattie

6

1 reference

Europe PubMed Central

19 September 2017

Gordon J Allan

7

1 reference

Europe PubMed Central

19 September 2017

David J Flint

8

1 reference

Europe PubMed Central

19 September 2017

language of work or name

0 references

publication date

27 February 2006

1 reference

Europe PubMed Central

19 September 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

19 September 2017

281

1 reference

Europe PubMed Central

19 September 2017

16

1 reference

Europe PubMed Central

19 September 2017

10883-10889

1 reference

Europe PubMed Central

19 September 2017

Growth hormone, acting in part through the insulin-like growth factor axis, rescues developmental, but not metabolic, activity in the mammary gland of mice expressing a single allele of the prolactin receptor.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508505200

21 January 2018

Insulin-like growth factor binding protein 5 and apoptosis in mammary epithelial cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508505200

21 January 2018

A quantitative RT-PCR study of the mRNA expression profile of the IGF axis during mammary gland development

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508505200

21 January 2018

Insulin-like growth factor binding protein-5 binds to plasminogen activator inhibitor-I

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508505200

21 January 2018

Effects of a non-IGF binding mutant of IGFBP-5 on cell death in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508505200

21 January 2018

A non-IGF binding mutant of IGFBP-3 modulates cell function in breast epithelial cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508505200

21 January 2018

Insulin-like growth factor binding proteins: IGF-dependent and -independent effects in the mammary gland

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508505200

21 January 2018

Epithelial mouse mammary cell line exhibiting normal morphogenesis in vivo and functional differentiation in vitro.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508505200

21 January 2018

Hormonal control of IGF-binding protein (IGFBP)-5 and IGFBP-2 secretion during differentiation of the HC11 mouse mammary epithelial cell line

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508505200

21 January 2018

Soluble fibrin preparations inhibit the reaction of plasmin with alpha 2-macroglobulin. Comparison with alpha 2-antiplasmin and leupeptin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508505200

21 January 2018

Specific amino acid substitutions determine the differential contribution of the N- and C-terminal domains of insulin-like growth factor (IGF)-binding protein-5 in binding IGF-I.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508505200

21 January 2018

Substitutions for hydrophobic amino acids in the N-terminal domains of IGFBP-3 and -5 markedly reduce IGF-I binding and alter their biologic actions

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508505200

21 January 2018

Overlap of IGF- and heparin-binding sites in rat IGF-binding protein-5.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508505200

21 January 2018

The carboxy-terminal domain of IGF-binding protein-5 inhibits heparin binding to a site in the central domain

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508505200

21 January 2018

Amino acids within the extracellular matrix (ECM) binding region (201-218) of rat insulin-like growth factor binding protein (IGFBP)-5 are important determinants in binding IGF-I.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508505200

21 January 2018

Molecular recognition characteristics in the insulin-like growth factor (IGF)-insulin-like growth factor binding protein -3/5 (IGFBP-3/5) heparin axis.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508505200

21 January 2018

Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508505200

21 January 2018

TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508505200

21 January 2018

The role of stasis in the clotting of blood and milk flows around solid objects

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508505200

21 January 2018

Cell migration: interactions among integrins, IGFs and IGFBPs

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508505200

21 January 2018

Mammary plasminogen activator: correlation with involution, hormonal modulation and comparison between normal and neoplastic tissue

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508505200

21 January 2018

Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508505200

21 January 2018

The plasminogen activation system in tumor growth, invasion, and metastasis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508505200

21 January 2018

Identifiers

10.1074/JBC.M508505200

1 reference

Europe PubMed Central

19 September 2017

1 reference

Europe PubMed Central

19 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40310685&oldid=1894983837"